Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/181776
Title: Cytosolic GPR37, but not GPR37L1, multimerization and its reversal by Parkin: A live cell imaging study
Author: Li, Tianyi
Oasa, Sho
Ciruela Alférez, Francisco
Terenius, Lars
Vukojević, Vladana
Svenningsson, Per
Keywords: Malaltia de Parkinson
Biomolècules
Parkinson's disease
Biomolecules
Issue Date: 25-Nov-2021
Publisher: Wiley
Abstract: Biochemical data have shown aggregated G protein-coupled receptor 37 (GPR37) in the cytoplasm and Lewy bodies in Parkinson's disease (PD). Properly folded GPR37 at the plasma membrane appears to be neuroprotective. GPR37, and its homologue GPR37L1, are orphan G protein-coupled receptors and their homo- and hetero-dimers have not been established. We therefore examined GPR37 and GPR37L1 dimerization and extended studies of multimerization of GPR37 to live cells. In this study, we investigated GPR37 and GPR37L1 dimerization and multimerization in live cells using three quantitative imaging methods: Fluorescence Cross-Correlation Spectroscopy, Förster Resonance Energy Transfer, and Fluorescence Lifetime Imaging Microscopy. Our data show that GPR37 and GPR37L1 form homo- and heterodimers in live N2a cells. Importantly, aggregation of GPR37, but not GPR37L1, was identified in the cytoplasm, which could be counteracted by Parkin overexpression. These data provide further evidence that GPR37 participate in cytosolic aggregation processes implicated in PD pathology.
Note: Reproducció del document publicat a: https://doi.org/10.1096/fj.202101213R
It is part of: The FASEB Journal, 2021, vol. 35, num. 12
URI: http://hdl.handle.net/2445/181776
Related resource: https://doi.org/10.1096/fj.202101213R
ISSN: 1530-6860
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Publicacions de projectes de recerca finançats per la UE

Files in This Item:
File Description SizeFormat 
fj.202101213R.pdf866.58 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons